| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), IMA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 493.7K | - | - | |
| CFO | 104.0K | - | - | |
| Other | 55.6K | $296.8K | - | |
| Other | 25.6K | - | - | |
| Dir | 16.0K | $95.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Buy | 125,000 | $16.00 | $2,000,000.00 | +16.7% | -44.1% | -76.1% | |
| Mar 30, 2021 | Formela Jean Francois70 | Director | Buy | 125,000 | $16.00 | $2,000,000.00 | +16.7% | -44.1% | -76.1% | |
| Mar 30, 2021 | Bonita David P64 | Director | Buy | 423,400 | $16.00 | $6,774,400.00 | -138.4% | -44.1% | -76.1% | |
| Mar 30, 2021 | Orbimed Advisors LLC66 | Director | Buy | 423,400 | $16.00 | $6,774,400.00 | -138.4% | -44.1% | -76.1% |